Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
References 1. 2
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management in adults (Mounjaro) and chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity (Zepbound)
The standard recommendation for a 10mg vial is 2mL of bacteriostatic water, producing a concentration of 5mg/mL
Literature References: How May GIP Enhance the Therapeutic Efficacy of GLP-1
US$ 20.85
US$ 24.55
US$ 26.29
US$ 20.07
US$ 22.49
US$ 27.15
US$ 22.97
US$ 19.99
US$ 28.68
